showed that the expression of EGFR on plasma exosomes was significantly higher in lung cancer patients compared to healthy controls, whereas the level of soluble EGFR in plasma showed no significant difference between healthy and disease conditions (92). The gene discussed is EGFR; the disease is lung carcinoma.